Inventor
YOSHIDA TETSUHIKO
JP59 patents
⚠️ This page may combine multiple inventors who share the name “YOSHIDA TETSUHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TOAGOSEI CO LTD
41 patentsUS11313862B2Apr 26, 2022
Method for diagnosing amyotrophic lateral sclerosis using signal peptide as indicator
TOAGOSEI CO LTD8 citations85
US7964556B1Jun 21, 2011
Antimicrobial peptides and use thereof
TOAGOSEI CO LTD9 citations83
US7482328B2Jan 27, 2009
Antimicrobial polypeptide and utilization thereof
TOAGOSEI CO LTD11 citations82
US12285476B2Apr 29, 2025
Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibody
TOAGOSEI CO LTD0 citations62
US11965011B2Apr 23, 2024
Antitumor peptide and use thereof
TOAGOSEI CO LTD0 citations62
US11927589B2Mar 12, 2024
Carrier peptide fragment for nucleolar localization and use thereof
TOAGOSEI CO LTD1 citations62
US11814448B2Nov 14, 2023
Carrier peptide fragment and use thereof
TOAGOSEI CO LTD0 citations62
US11780903B2Oct 10, 2023
Peptide suppressing binding of CTLA4 to B7 proteins, and use thereof
TOAGOSEI CO LTD0 citations62
US11603395B2Mar 14, 2023
Antitumor peptide and use thereof
TOAGOSEI CO LTD0 citations62
US11505589B2Nov 22, 2022
Antitumor peptide and use thereof
TOAGOSEI CO LTD0 citations62
US11352408B2Jun 7, 2022
Antitumor peptide having PD-1 signal sequence and utilization thereof
TOAGOSEI CO LTD0 citations62
US11339203B2May 24, 2022
Antitumor peptide and use thereof
TOAGOSEI CO LTD0 citations62
US11299555B2Apr 12, 2022
Method for diagnosing alzheimer's disease using signal peptide as indicator
TOAGOSEI CO LTD1 citations62
US10100284B2Oct 16, 2018
Method for inducing differentiation of pluripotent stem cells into endodermal cells
TOAGOSEI CO LTD2 citations62
US9353350B2May 31, 2016
Method for producing multipolar cell
TOAGOSEI CO LTD2 citations62
US9353351B2May 31, 2016
Method for producing multipolar cell
TOAGOSEI CO LTD2 citations62
US9296787B2Mar 29, 2016
Antitumor peptide and use thereof
TOAGOSEI CO LTD2 citations62
US11767345B2Sep 26, 2023
Antiviral peptide and use thereof
TOAGOSEI CO LTD0 citations60
US11155582B2Oct 26, 2021
Antiviral peptide and use thereof
TOAGOSEI CO LTD0 citations60
US7674771B2Mar 9, 2010
Antimicrobial peptides and utilization of the same
TOAGOSEI CO LTD4 citations60
US11230586B2Jan 25, 2022
Exosome production method
TOAGOSEI CO LTD1 citations59
US10981953B2Apr 20, 2021
Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
TOAGOSEI CO LTD0 citations58
US11472845B2Oct 18, 2022
Antitumor peptide and use thereof
TOAGOSEI CO LTD0 citations57
US11285195B2Mar 29, 2022
Pharmaceutical composition for inhibiting expression of CD47 in tumor cells and use of same
TOAGOSEI CO LTD0 citations55
US11359180B2Jun 14, 2022
Method for producing myocardial cells using synthetic peptide
TOAGOSEI CO LTD0 citations52
US10421944B2Sep 24, 2019
Method for producing neural stem cells using synthetic peptide
TOAGOSEI CO LTD0 citations52
US10112977B2Oct 30, 2018
Peptide for inducing multinucleation in cells, and use therefor
TOAGOSEI CO LTD1 citations52
US7893031B2Feb 22, 2011
Neuronal differentiation inhibitor peptide and use thereof
TOAGOSEI CO LTD0 citations52
US7186510B2Mar 6, 2007
Method for evaluating uniformity of spots on an array
TOAGOSEI CO LTD1 citations52
US6907393B1Jun 14, 2005
Methods for screening candidates for artificial promotors
TOAGOSEI CO LTD0 citations52
US12392770B2Aug 19, 2025
Foreign substance introduction construct and use thereof
TOAGOSEI CO LTD0 citations51
US10125168B2Nov 13, 2018
Synthetic peptide for adjusting balance between presence of type 1 TNF receptor and type 2 TNF receptor and use thereof
TOAGOSEI CO LTD0 citations51
US9856293B2Jan 2, 2018
Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein
TOAGOSEI CO LTD0 citations51
US9480727B2Nov 1, 2016
Synthetic peptide for inhibiting expression of type 2 TNF receptor and use thereof
TOAGOSEI CO LTD1 citations51
US9370182B2Jun 21, 2016
Antimicrobial peptide and use thereof
TOAGOSEI CO LTD0 citations51
US7615534B2Nov 10, 2009
Antimicrobial peptides and use thereof
TOAGOSEI CO LTD0 citations51
US10745448B2Aug 18, 2020
Antiviral peptide and use therefor
TOAGOSEI CO LTD0 citations50
US11324831B2May 10, 2022
Method for introducing exogenous substance into cell, and material used in said method
TOAGOSEI CO LTD0 citations48
US12209242B2Jan 28, 2025
siRNA based on RNA sequence of SARS-CoV-2 and use thereof
TOAGOSEI CO LTD0 citations47
US9133437B2Sep 15, 2015
Cell proliferation-promoting peptide and use thereof
TOAGOSEI CO LTD0 citations46
US10046022B2Aug 14, 2018
Synthetic peptide that increases radiosensitivity of tumor cells and use of same
TOAGOSEI CO LTD1 citations45
TOA GOSEI KABUSHIKI KAISHA
2 patentsYOSHIDA TETSUHIKO
2 patentsKOBAYASHI NAHOKO
2 patentsFUKUSHIMA HITOSHI
1 patentSHIMIZU NOBUYOSHI
1 patentLIGHTRON CO LTD
1 patentShowing the top 50 of 59 patents by PatentIndex Score.